Childhood leukodystrophies: a clinical perspective

References

• Schiffmann R, van der Knaap MS. Invited article: an MRI-based approach to the diagnosis of white matter disorders. Neurology72(8), 750–759 (2009).
   PubMed Web of Science ®Google Scholar
• Steenweg ME, Vanderver A, Blaser S et al. Magnetic resonance imaging pattern recognition in hypomyelinating disorders. Brain133(10), 2971–2982 (2010).
   PubMed Web of Science ®Google Scholar
• Lin J, Faria EC, Da Rocha AJ et al. Leukoencephalopathy with brainstem and spinal cord involvement and normal lactate: a new mutation in the DARS2 gene. J. Child Neurol.25(11), 1425–1428 (2010).
   PubMed Web of Science ®Google Scholar
• Jose RA, Tulio BF, Carlos MMA Jr et al. Lactate detection by MRS in mitochondrial encephalopathy: optimization of technical parameters. J. Neuroimaging18(1), 1–8 (2008).
   PubMedGoogle Scholar
• Loes DJ, Fatemi A, Melhem ER et al. Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy. Neurology61(3), 369–374 (2003).
   PubMed Web of Science ®Google Scholar
• Beam D, Poe MD, Provenzale JM et al. Outcomes of unrelated umbilical cord blood transplantation for X-linked adrenoleukodystrophy. Biol. Blood Marrow Transplant.13(6), 665–674 (2007).
   PubMed Web of Science ®Google Scholar
• Provenzale JM, Peddi S, Kurtzberg J, Poe MD, Mukundan S, Escolar M. Correlation of neurodevelopmental features and MRI findings in infantile Krabbe’s disease. AJR Am. J. Roentgenol.192(1), 59–65 (2009).
   PubMedGoogle Scholar
• Eichler F, Grodd W, Grant E et al. Metachromatic leukodystrophy: a scoring system for brain MR imaging observations. AJNR Am. J. Neuroradiol.30(10), 1893–1897 (2009).
   PubMedGoogle Scholar
• Van der Knaap MS, Valk J. Magnetic Resonance of Myelination and Myelin Disorders. Birkhäuser (Ed.). Springer, Berlin. Germany (2005).
   Google Scholar
• Husain AM, Altuwaijri M, Aldosari M. Krabbe disease: neurophysiologic studies and MRI correlations. Neurology63(4), 617–620 (2004).
   PubMedGoogle Scholar
• Siddiqi ZA, Sanders DB, Massey JM. Peripheral neuropathy in Krabbe disease: electrodiagnostic findings. Neurology67(2), 263–267 (2006).
   PubMedGoogle Scholar
• Aubourg P, Adamsbaum C, Lavallard-Rousseau MC et al. Brain MRI and electrophysiologic abnormalities in preclinical and clinical adrenomyeloneuropathy. Neurology42(1), 85–91 (1992).
   PubMedGoogle Scholar
• Moser HW, Raymond GV, Dubey P. Adrenoleukodystrophy: new approaches to a neurodegenerative disease. JAMA294(24), 3131–3134 (2005).
   PubMed Web of Science ®Google Scholar
• Dubey P, Raymond GV, Moser AB, Kharkar S, Bezman L, Moser HW. Adrenal insufficiency in asymptomatic adrenoleukodystrophy patients identified by very long-chain fatty acid screening. J. Pediatr.146(4), 528–532 (2005).
   PubMedGoogle Scholar
• Laureti S, Casucci G, Santeusanio F, Angeletti G, Aubourg P, Brunetti P. X-linked adrenoleukodystrophy is a frequent cause of idiopathic Addison’s disease in young adult male patients. J. Clin. Endocrinol. Metab.81(2), 470–474 (1996).
   PubMed Web of Science ®Google Scholar
• van der Knaap MS, Pronk JC, Scheper GC. Vanishing white matter disease. Lancet Neurol.5(5), 413–423 (2006).
   PubMed Web of Science ®Google Scholar
• van der Knaap MS, van Berkel CG, Herms J et al. eIF2B-related disorders: antenatal onset and involvement of multiple organs. Am. J. Hum. Genet.73(6), 1199–1207 (2003).
   PubMed Web of Science ®Google Scholar
• Garavelli L, Rosato S, Mele A et al. Massive hemobilia and papillomatosis of the gallbladder in metachromatic leukodystrophy: a life-threatening condition. Neuropediatrics40(6), 284–286 (2009).
   PubMedGoogle Scholar
• Mahmood A, Berry J, Wenger DA et al. Metachromatic leukodystrophy: a case of triplets with the late infantile variant and a systematic review of the literature. J. Child Neurol.25(5), 572–580 (2009).
   PubMedGoogle Scholar
• Klick JC, Hauer J. Pediatric palliative care. Curr. Probl. Pediatr. Adolesc. Health Care40(6), 120–151 (2010).
   PubMed Web of Science ®Google Scholar
• Hauer JM, Wical BS, Charnas L. Gabapentin successfully manages chronic unexplained irritability in children with severe neurologic impairment. Pediatrics119(2), e519–e522 (2007).
   PubMed Web of Science ®Google Scholar
• Matzner U, Lullmann-Rauch R, Stroobants S et al. Enzyme replacement improves ataxic gait and central nervous system histopathology in a mouse model of metachromatic leukodystrophy. Mol. Ther.17(4), 600–606 (2009).
   PubMed Web of Science ®Google Scholar
• Kondo Y, Wenger DA, Gallo V, Duncan ID. Galactocerebrosidase-deficient oligodendrocytes maintain stable central myelin by exogenous replacement of the missing enzyme in mice. Proc. Natl Acad. Sci. USA102(51), 18670–18675 (2005).
   PubMedGoogle Scholar
• Moser HW, Raymond GV, Lu SE et al. Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo’s oil. Arch. Neurol.62(7), 1073–1080 (2005).
   PubMed Web of Science ®Google Scholar
• Aubourg P, Blanche S, Jambaque I et al. Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation. N. Engl. J. Med.322(26), 1860–1866 (1990).
   PubMed Web of Science ®Google Scholar
• Peters C, Charnas LR, Tan Y et al. Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. Blood104(3), 881–888 (2004).
   PubMed Web of Science ®Google Scholar
• Escolar ML, Poe MD, Provenzale JM et al. Transplantation of umbilical-cord blood in babies with infantile Krabbe’s disease. N. Engl. J. Med.352(20), 2069–2081 (2005).
   PubMed Web of Science ®Google Scholar
• Biffi A, Lucchini G, Rovelli A, Sessa M. Metachromatic leukodystrophy: an overview of current and prospective treatments. Bone Marrow Transplant.42(Suppl. 2), S2–S6 (2008).
   PubMed Web of Science ®Google Scholar
• Orchard PJ, Tolar J. Transplant outcomes in leukodystrophies. Semin. Hematol.47(1), 70–78 (2010).
   PubMed Web of Science ®Google Scholar
• Benhamida S, Pflumio F, Dubart-Kupperschmitt A et al. Transduced CD34+ cells from adrenoleukodystrophy patients with HIV-derived vector mediate long-term engraftment of NOD/SCID mice. Mol. Ther.7(3), 317–324 (2003).
   PubMed Web of Science ®Google Scholar
• Glazier AM, Nadeau JH, Aitman TJ. Finding genes that underlie complex traits. Science298(5602), 2345–2349 (2002).
   PubMed Web of Science ®Google Scholar
• Thibert R, Hyland K, Chiles J, Steinberg S, Eichler F. Levodopa response reveals sepiapterin reductase deficiency in a female heterozygote with adrenoleukodystrophy. J. Inherit. Metab. Dis. (2011) (In press).
   Google Scholar
• Hauer J. Identifying and managing sources of pain and distress in children with neurological impairment. Pediatr. Ann.39(4), 198–205 (2010).
   PubMedGoogle Scholar
• Malcolm C, Forbat L, Anderson G, Gibson F, Hain R. Challenging symptom profiles of life-limiting conditions in children: a survey of care professionals and families. Palliat. Med.25(4), 357–364 (2011).
   PubMedGoogle Scholar
• Kaiser J. Human genetics. Affordable ‘exomes’ fill gaps in a catalog of rare diseases. Science330(6006), 903 (2010).
   PubMed Web of Science ®Google Scholar
• Metzker ML. Sequencing technologies – the next generation. Nat. Rev. Genet.11(1), 31–46 (2010).
   PubMed Web of Science ®Google Scholar
• Nikles J, Mitchell GK, Schluter P et al. Aggregating single patient (n-of-1) trials in populations where recruitment and retention was difficult: the case of palliative care. J. Clin. Epidemiol.64(5), 471–480 (2011).
   PubMed Web of Science ®Google Scholar
• Davison JE, Davies NP, English MW et al. Magnetic resonance spectroscopy in the diagnostic evaluation of brainstem lesions in Alexander disease. J. Child Neurol.26(3), 356–360 (2011).
   PubMedGoogle Scholar
• Orcesi S, Pessagno A, Biancheri R et al. Aicardi–Goutières syndrome presenting atypically as a sub-acute leukoencephalopathy. Eur. J. Paediatr. Neurol.12(5), 408–411 (2008).
   PubMed Web of Science ®Google Scholar
• Orcesi S, La Piana R, Fazzi E. Aicardi–Goutières syndrome. Br. Med. Bull.89, 183–201 (2009).
   PubMed Web of Science ®Google Scholar
• Zano S, Malik R, Szucs S, Matalon R, Viola RE. Modification of aspartoacylase for potential use in enzyme replacement therapy for the treatment of Canavan disease. Mol. Genet. Metab.102(2), 176–180 (2011).
   PubMedGoogle Scholar
• Hartley J, Westmacott R, Decker J, Shroff M, Yoon G. Childhood-onset CADASIL: clinical, imaging, and neurocognitive features. J. Child Neurol.25(5), 623–627 (2010).
   PubMedGoogle Scholar
• Bjorkhem I, Hansson M. Cerebrotendinous xanthomatosis: an inborn error in bile acid synthesis with defined mutations but still a challenge. Biochem. Biophys. Res. Commun.396(1), 46–49 (2010).
   PubMedGoogle Scholar
• Lancaster JL, Cody JD, Andrews T, Hardies LJ, Hale DE, Fox PT. Myelination in children with partial deletions of chromosome 18q. AJNR Am. J. Neuroradiol.26(3), 447–454 (2005).
   PubMedGoogle Scholar
• Jaeken J, Matthijs G. Congenital disorders of glycosylation: a rapidly expanding disease family. Annu. Rev. Genomics Hum. Genet.8, 261–278 (2007).
   PubMed Web of Science ®Google Scholar
• Henneke M, Diekmann S, Ohlenbusch A et al. RNASET2-deficient cystic leukoencephalopathy resembles congenital cytomegalovirus brain infection. Nat. Genet.41(7), 773–775 (2009).
   PubMed Web of Science ®Google Scholar
• Steinfeld R, Grapp M, Kraetzner R et al. Folate receptor α defect causes cerebral folate transport deficiency: a treatable neurodegenerative disorder associated with disturbed myelin metabolism. Am. J. Hum. Genet.85(3), 354–363 (2009).
   PubMed Web of Science ®Google Scholar
• Mamourian AC, Hopkin JR, Chawla S, Poptani H. Characteristic MR spectroscopy in fucosidosis: in vitro investigation. Pediatr. Radiol.40(8), 1446–1449 (2010).
   PubMedGoogle Scholar
• Tazir M, Nouioua S, Magy L et al. Phenotypic variability in giant axonal neuropathy. Neuromuscul. Disord.19(4), 270–274 (2009).
   PubMed Web of Science ®Google Scholar
• Srinivasan J, Coleman L, Kornberg AJ. Juvenile onset globoid cell leukodystrophy masquerading as XL-adrenoleukodystrophy. J. Paediatr. Child Health44(7–8), 459–461 (2008).
   PubMedGoogle Scholar
• Del Toro M, Arranz JA, Macaya A et al. Progressive vacuolating glycine leukoencephalopathy with pulmonary hypertension. Ann. Neurol.60(1), 148–152 (2006).
   PubMedGoogle Scholar
• van der Knaap MS, Linnankivi T, Paetau A et al. Hypomyelination with atrophy of the basal ganglia and cerebellum: follow-up and pathology. Neurology69(2), 166–171 (2007).
   PubMed Web of Science ®Google Scholar
• Rossi A, Biancheri R, Zara F et al. Hypomyelination and congenital cataract: neuroimaging features of a novel inherited white matter disorder. Am. J. Neuroradiol.29(2), 301–305 (2008).
   PubMedGoogle Scholar
• Orcesi S, Tonduti D, Uggetti C, Larizza D, Fazzi E, Balottin U. New case of 4H syndrome and a review of the literature. Pediatr. Neurol.42(5), 359–364 (2010).
   PubMedGoogle Scholar
• Vaurs-Barriere C, Deville M, Sarret C et al. Pelizaeus–Merzbacher-like disease presentation of MCT8 mutated male subjects. Ann. Neurol.65(1), 114–118 (2009).
   PubMed Web of Science ®Google Scholar
• Bernard G, Thiffault I, Tetreault M et al. Tremor-ataxia with central hypomyelination (TACH) leukodystrophy maps to chromosome 10q22.3–10q23.31. Neurogenetics11(4), 457–464 (2010).
   PubMedGoogle Scholar
• Carrilho I, Santos M, Guimaraes A et al. Infantile neuroaxonal dystrophy: what’s most important for the diagnosis? Eur. J. Paediatr. Neurol.12(6), 491–500 (2008).
   PubMedGoogle Scholar
• Briggs TA, Abdel-Salam GM, Balicki M et al. Cerebroretinal microangiopathy with calcifications and cysts (CRMCC). Am. J. Med. Genet.146A(2), 182–190 (2008).
   PubMed Web of Science ®Google Scholar
• Ferreira M, Torraco A, Rizza T et al. Progressive cavitating leukoencephalopathy associated with respiratory chain complex I deficiency and a novel mutation in NDUFS1. Neurogenetics12(1), 9–17 (2011).
   PubMed Web of Science ®Google Scholar
• Neubauer BA, Stefanova I, Hubner CA et al. A new type of leukoencephalopathy with metaphyseal chondrodysplasia maps to Xq25-q27. Neurology67(4), 587–591 (2006).
   PubMedGoogle Scholar
• van der Knaap MS, Lai V, Kohler W et al. Megalencephalic leukoencephalopathy with cysts without MLC1 defect. Ann. Neurol.67(6), 834–837 (2010).
   PubMed Web of Science ®Google Scholar
• Naidu S, Bibat G, Lin D et al. Progressive cavitating leukoencephalopathy: a novel childhood disease. Ann. Neurol.58(6), 929–938 (2005).
   PubMed Web of Science ®Google Scholar
• Lopez-Hernandez T, Ridder MC, Montolio M et al. Mutant glialCAM causes megalencephalic leukoencephalopathy with subcortical cysts, benign familial macrocephaly, and macrocephaly with retardation and autism. Am. J. Hum. Genet.88(4), 422–432 (2011).
   PubMed Web of Science ®Google Scholar
• Lerman-Sagie T, Leshinsky-Silver E, Watemberg N, Luckman Y, Lev D. White matter involvement in mitochondrial diseases. Mol. Genet. Metab.84(2), 127–136 (2005).
   PubMedGoogle Scholar
• Timothy J, Geller T. SURF-1 gene mutation associated with leukoencephalopathy in a 2-year-old. J. Child Neurol.24, 1206–1301 (2009).
   Google Scholar
• Biancheri R, Rossi D, Cassandrini D, Rossi A, Bruno C, Santorelli FM. Cavitating leukoencephalopathy in a child carrying the mitochondrial A8344G mutation. AJNR Am. J. Neuroradiol.31(9), E78–E79 (2010).
   PubMedGoogle Scholar
• Artigalas OA, da Silva LR, Burin M et al. Multiple sulfatase deficiency: clinical report and description of two novel mutations in a Brazilian patient. Meta. Brain Dis.24(3), 493–500 (2009).
   PubMedGoogle Scholar
• Steenweg ME, Jakobs C, Errami A et al. An overview of L-2-hydroxyglutarate dehydrogenase gene (L2HGDH) variants: a genotype–phenotype study. Hum Mutat31(4), 380–390 (2010).
   PubMedGoogle Scholar
• Henneke M, Combes P, Diekmann S et al.GJA12 mutations are a rare cause of Pelizaeus–Merzbacher-like disease. Neurology70(10), 748–754 (2008).
   PubMed Web of Science ®Google Scholar
• Feinstein M, Markus B, Noyman I et al. Pelizaeus–Merzbacher-like disease caused by AIMP1/p43 homozygous mutation. Am. J. Hum. Genet.87(6), 820–828 (2010).
   PubMed Web of Science ®Google Scholar
• Mochel F, Engelke UF, Barritault J et al. Elevated CSF N-acetylaspartylglutamate in patients with free sialic acid storage diseases. Neurology74(4), 302–305 (2010).
   PubMedGoogle Scholar
• Harreld JH, Smith EC, Prose NS, Puri PK, Barboriak DP. Trichothiodystrophy with dysmyelination and central osteosclerosis. Am. J. Neuroradiol.31(1), 129–130 (2010).
   PubMedGoogle Scholar
• van der Lei HDW, van Berkel CGM, van Wieringen WN et al. Genotype–phenotype correlation in vanishing white matter disease. Neurology75(17), 1555–1559 (2010).
   PubMedGoogle Scholar
• Wolf NI, Harting I, Boltshauser E. Leukoencephalopathy with ataxia, hypodontia, and hypomyelination. Neurology64(8), 1461–1644 (2006).
   Google Scholar
• van der Knaap MS, Ramesh V, Schiffmann R et al. Alexander disease: ventricular garlands and abnormalities of the medulla and spinal cord. Neurology66(4), 494–498 (2006).
   PubMedGoogle Scholar
• Krishnamoorthy KS, Eichler FS, Goyal NA, Small JE, Snuderl M. Case records of the Massachusetts General Hospital. Case 3-2010. A 5-month-old boy with developmental delay and irritability. N. Engl. J. Med.362(4), 346–356 (2010).
   PubMedGoogle Scholar
• Dastych M, Gottwaldova J, Pohludka M, Prikryl P, Benovska M. Determination of asialotransferrin in the cerebrospinal fluid with the HPLC method. Scand. J. Clin. Lab. Invest.70(2), 87–91 (2010).
   PubMed Web of Science ®Google Scholar
• Callahan JW, Skomorowski MA. Diagnosis of Krabbe disease by use of a natural substrate. Methods Mol. Biol.347, 321–330 (2006).
   PubMedGoogle Scholar
• Gorg M, Wilck W, Granitzny B et al. Stabilization of juvenile metachromatic leukodystrophy after bone marrow transplantation: a 13-year follow-up. J. Child Neurol.22(9), 1139–1142 (2007).
   PubMedGoogle Scholar